Humana (HUM) analyst forecast and price target
Analyst forecast
Consensus of 29 analyst ratings
Based on 13 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| JP Morgan | Maintained | Neutral | $393.00 from $316.00 | Aug 10, 2026 |
| Morgan Stanley | Upgraded | Underweight → Equal-Weight | $370.00 from $249.00 | Aug 5, 2026 |
| Barclays | Maintained | Equal-Weight | $407.00 from $344.00 | Jul 31, 2026 |
| TD Cowen | Maintained | Hold | $370.00 from $350.00 | Jul 31, 2026 |
| Raymond James | Downgraded | Outperform → Market Perform | — | Jul 30, 2026 |
| Evercore ISI Group | Upgraded | In-Line → Outperform | $480.00 from $430.00 | Jul 30, 2026 |
| Guggenheim | Maintained | Buy | $471.00 from $269.00 | Jul 30, 2026 |
| UBS | Maintained | Neutral | $405.00 from $320.00 | Jul 30, 2026 |
| Truist Securities | Maintained | Hold | $415.00 from $320.00 | Jul 14, 2026 |
| TD Cowen | Maintained | Hold | $350.00 from $211.00 | Jul 14, 2026 |
| Wells Fargo | Upgraded | Equal-Weight → Overweight | $502.00 from $227.00 | Jul 13, 2026 |
| RBC Capital | Maintained | Sector Perform | $415.00 from $246.00 | Jul 9, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $300.00 from $264.00 | Jul 7, 2026 |
| B of A Securities | Maintained | Neutral | $380.00 from $340.00 | Jun 24, 2026 |
| Evercore ISI Group | Maintained | In-Line | $370.00 from $250.00 | Jun 11, 2026 |
| JP Morgan | Maintained | Neutral | $316.00 from $214.00 | Jun 8, 2026 |
| Mizuho | Maintained | Outperform | $390.00 from $335.00 | Jun 8, 2026 |
| Morgan Stanley | Maintained | Underweight | $249.00 from $217.00 | Jun 4, 2026 |
| B of A Securities | Maintained | Neutral | $340.00 from $267.00 | Jun 4, 2026 |
| Truist Securities | Maintained | Hold | $320.00 from $270.00 | Jun 1, 2026 |
Frequently asked questions
What is the price target for HUM stock?
The average 12-month analyst price target for Humana (HUM) is $407.54, with a high estimate of $502.00 and a low of $300.00, across 13 analysts.
Is HUM a buy, sell, or hold?
Analysts covering Humana currently average a Hold rating: 12 buy, 15 hold and 2 sell, from 29 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for HUM?
The average price target of $407.54 implies 5.75% upside from the last price of $385.37.
What is the latest analyst rating on HUM?
On Aug 10, 2026, JP Morgan maintained Humana at Neutral with a price target of $393.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.